Corcept Therapeutics
CORT
#2478
Rank
C$8.19 B
Marketcap
$78.18
Share price
-0.16%
Change (1 day)
119.61%
Change (1 year)

Corcept Therapeutics (CORT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$0.20 Billion

According to Corcept Therapeutics 's latest financial reports the company's total liabilities are C$0.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Corcept Therapeutics - Total liabilities on balance sheet (from 2003 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$0.15 B37.55%
2022-12-31C$0.11 B81.17%
2021-12-31C$61.1 M-0.96%
2020-12-31C$61.7 M14.87%
2019-12-31C$53.71 M10.12%
2018-12-31C$48.78 M31.22%
2017-12-31C$37.17 M1.06%
2016-12-31C$36.78 M-20.61%
2015-12-31C$46.33 M5.03%
2014-12-31C$44.11 M-1.46%
2013-12-31C$44.77 M20.42%
2012-12-31C$37.17 M627.24%
2011-12-31C$5.11 M32.5%
2010-12-31C$3.85 M51.59%
2009-12-31C$2.54 M-27.01%
2008-12-31C$3.48 M16.13%
2007-12-31C$3 M-27.19%
2006-12-31C$4.12 M-0.59%
2005-12-31C$4.14 M89.35%
2004-12-31C$2.19 M-96.1%
2003-12-31C$56.1 M-18.77%
2002-12-31C$69.07 M2201.5%
2001-12-31C$3 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$150.96 B 74,255.32%๐Ÿ‡บ๐Ÿ‡ธ USA
C$106.76 B 52,484.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$83.88 B 41,216.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$85.56 B 42,043.69%๐Ÿ‡บ๐Ÿ‡ธ USA
C$177.19 B 87,175.65%๐Ÿ‡บ๐Ÿ‡ธ USA
C$101.87 B 50,079.48%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.97 B 378.98%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.93 B 360.46%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.00 B 888.71%๐Ÿ‡บ๐Ÿ‡ธ USA